Mark W Kroll Haemonetics Corp (HAE) insider trading activity

HAE Quotes by TradingView

Mark W Kroll is Director of HAEMONETICS CORP. Currently has a direct ownership of 20,664 shares of HAE, which is worth approximately $1.6 Million. The most recent transaction as insider was on Jul 25, 2024, when has been sold 2,207 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.7K
0% 3M change
11.96% 12M change
Total Value Held $1.6 Million

MARK W KROLL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 25 2024
BUY
Grant, award, or other acquisition
-
2,207 Added 9.65%
20,664 Common Stock
Aug 04 2023
BUY
Grant, award, or other acquisition
-
2,226 Added 10.76%
18,457 Common Stock
Aug 15 2022
SELL
Open market or private sale
$590,859 $73.71 p/Share
8,016 Reduced 33.06%
16,231 Common Stock
Aug 05 2022
BUY
Grant, award, or other acquisition
-
2,730 Added 10.12%
24,247 Common Stock
Aug 06 2021
BUY
Grant, award, or other acquisition
-
3,077 Added 12.51%
21,517 Common Stock
May 26 2021
SELL
Open market or private sale
$650,896 $55.1 p/Share
11,813 Reduced 39.05%
18,440 Common Stock
May 26 2021
BUY
Exercise of conversion of derivative security
$367,532 $35.5 p/Share
10,353 Added 25.5%
30,253 Common Stock

Also insider at

AXON
AXON ENTERPRISE, INC. Industrials
MWK

Mark W Kroll

Director
Boston, MA

Track Institutional and Insider Activities on HAE

Follow HAEMONETICS CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HAE shares.

Notify only if

Insider Trading

Get notified when an Haemonetics Corp insider buys or sells HAE shares.

Notify only if

News

Receive news related to HAEMONETICS CORP

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on HAE